Sign Up to like & get
recommendations!
1
Published in 2019 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2019.08.473
Abstract: BACKGROUND In Colombia, hemophilia is considered a high-cost disease, and hemophilia A with high-titer inhibitors may be responsible for a significant economic pressure on the Colombian health system. OBJECTIVES To estimate the direct cost of…
read more here.
Keywords:
patients hemophilia;
titer inhibitors;
hemophilia high;
high titer ... See more keywords